Medical News

RSS

Bronx-Lebanon Hospital Center's new children's outpatient facility named in honor of Alex Rodriguez

Alex Rodriguez joined Bronx-Lebanon Hospital Center President and CEO Miguel A. Fuentes, Jr., as well as board members, staff and pediatric patients at a ceremony to dedicate a new children's outpatient center named in his honor on Wednesday, June 30, 2010.

3 Jul 2010

Hospitals in Iowa, Kentucky and Massachusetts face new challenges, opportunities

Quad-City Times: "A proposed change in Medicare reimbursement could increase payments to Iowa hospitals by more than $12.5 million next year. At the same time, a rule change on reimbursement to doctors could boost their Medicare payments by 5 percent beginning next year. 'This will mean a great deal to Iowa hospitals that have been struggling for many years,' said U.S. Rep. Bruce Braley, D-Iowa.

3 Jul 2010

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Endo Pharmaceuticals today announced the successful completion of the tender offer by its wholly owned subsidiary, HT Acquisition Corp., for all of the outstanding shares of common stock of HealthTronics, Inc..

3 Jul 2010

Strativa receives FDA approval for Zuplenz oral soluble film

Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.

3 Jul 2010

Virginia challenge to health overhaul goes to court

Justice Department and the state of Virginia lawyers faced off Thursday in the first challenge of the federal government's authority to require people purchase health insurance.

3 Jul 2010

Cyanotech regains Nasdaq compliance

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced that it had received notice from the Nasdaq Stock Market on June 30, 2010 of full compliance with Listing Rules required for its continued listing on the The Nasdaq Capital Market.

3 Jul 2010

Watson acquires U.S. rights to CRINONE, PROCHIEVE product line from Columbia Laboratories

Watson Pharmaceuticals, Inc. today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock.

3 Jul 2010

Today's OpEds: Insurance premium caps; Doc shortage; High-risk pool

The insurer's proposed premium hikes are staggering, but the problem is that medical costs have been growing considerably faster than inflation. AB 2578 would help put a check on unjustified hikes ... The Assembly passed the bill last month, and we urge the Senate to follow suit (7/2).

3 Jul 2010

Exposure to carbon monoxide, air pollution does not increase preterm delivery risk

While pregnant women may worry about the effects of air pollution on their health and that of their developing child, exposure to carbon monoxide and fine particles in the air during pregnancy does not appear to increase the risk of preterm delivery or preeclampsia -- a serious condition that arises only during pregnancy -- according to results of a study headed by a University at Buffalo epidemiologist.

2 Jul 2010

WaferGen Biosystems to raise $7 million in registered direct offering

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced that it has received commitments from certain investors to purchase approximately $7 million of previously unissued securities in a registered direct offering. The investors include the Chairman and CEO, Alnoor Shivji, who has agreed to purchase $1 million of securities in the registered direct offering.

2 Jul 2010

Watson Laboratories receives FDA approval for Tacrolimus ANDA

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Tacrolimus 5 mg capsules, the generic equivalent to Astellas' Prograf® capsules.

2 Jul 2010

Eli Lilly, Alnara sign definitive merger agreement

Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).

2 Jul 2010

Studies demonstrate analgesic properties of synthetic cannabinoid

A new compound similar to the active component of marijuana (cannabis) might provide effective pain relief without the mental and physical side effects of cannabis, according to a study in the July issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jul 2010

Study: ONGLYZA and metformin improve HbA1c levels for adult patients with type 2 diabetes at 76-weeks

Bristol-Myers Squibb Company and AstraZeneca today announced results up to 76-weeks from a Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy with metformin, which produced long-term glycemic improvement (as measured by glycosylated hemoglobin level (HbA1c)) in treatment-naive adults with type 2 diabetes mellitus inadequately controlled on diet and exercise compared to treatment with an investigational 10 mg dose of saxagliptin or metformin alone.

2 Jul 2010

PhenotypeIT launches integrated Corporate Health and Wellness Management Platform

PhenotypeIT, Inc. announced today the launch of its PhIT™ platform, the first truly integrated Corporate Health and Wellness Management Platform that predicts disease and chronic health conditions before their onset and provides critical aggregated data to employers to reduce costs. The PhIT platform accurately assesses the impact of current and future health conditions, and assesses the cost implications of these conditions and related loss of productivity for the employer.

2 Jul 2010

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Just one year after The University of Texas MD Anderson Cancer Center launched its secured, Web-based portal for personal health information, more than 28,000 patients (57 percent) who logged into myMDAnderson - a personalized, online connection to the center - have accessed their personal medical information, test results and records.

2 Jul 2010

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

Utilizing Fluidigm Corporation's Dynamic Array™ and Digital Array™ integrated fluidic circuits (IFCs), Stanford University researchers to have discovered a much larger spectrum of differences between individual cells than has previously been demonstrated. Among these differences are the communication capabilities that emerge from the interactions of genetic circuitry that mediates cell-to-cell communication.

2 Jul 2010

XenoPort reports equity awards to new employee under Inducement Award Plan

XenoPort, Inc. reported today that equity awards were made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee was granted options to purchase an aggregate of 75,000 shares of XenoPort's common stock and restricted stock units representing an aggregate of 5,000 shares of XenoPort's common stock.

2 Jul 2010

Modified Citrus Pectin holds promise against prostate cancer

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

2 Jul 2010

HMS acquires AMG-SIU for $26.2 million

HMS today announced it has signed a definitive agreement to acquire privately-held Allied Management Group (AMG-SIU), a leading provider of fraud, waste, and abuse prevention and detection solutions for healthcare payors, in an all-cash transaction. AMG-SIU is based in Santa Ana, California.

2 Jul 2010

Medical News

Bronx-Lebanon Hospital Center's new children's outpatient facility named in honor of Alex Rodriguez

Hospitals in Iowa, Kentucky and Massachusetts face new challenges, opportunities

Endo subsidiary successfully completes tender offer for HealthTronics' outstanding common stock

Strativa receives FDA approval for Zuplenz oral soluble film

Virginia challenge to health overhaul goes to court

Cyanotech regains Nasdaq compliance

Watson acquires U.S. rights to CRINONE, PROCHIEVE product line from Columbia Laboratories

Today's OpEds: Insurance premium caps; Doc shortage; High-risk pool

Exposure to carbon monoxide, air pollution does not increase preterm delivery risk

WaferGen Biosystems to raise $7 million in registered direct offering

Watson Laboratories receives FDA approval for Tacrolimus ANDA

Eli Lilly, Alnara sign definitive merger agreement

Studies demonstrate analgesic properties of synthetic cannabinoid

Study: ONGLYZA and metformin improve HbA1c levels for adult patients with type 2 diabetes at 76-weeks

PhenotypeIT launches integrated Corporate Health and Wellness Management Platform

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Fluidigm's IFC platform products help perform digital-PCR measurements on single gene

XenoPort reports equity awards to new employee under Inducement Award Plan

Modified Citrus Pectin holds promise against prostate cancer

HMS acquires AMG-SIU for $26.2 million

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News